ANJI PHARMACEUTICALS
Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our strategy and execution. We have assembled a world-class team of scientist entrepreneurs who are committed to accelerate innovative medicines in China and worldwide.
ANJI PHARMACEUTICALS
Social Links:
Industry:
Pharmaceutical
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.anjipharma.com
Total Employee:
1+
Status:
Active
Total Funding:
105 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Global Site Tag
Similar Organizations
KBP Biosciences
A multinational clinical stage biotechnology company.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Founder
Investors List
Xiamen Changrong Investment Management
Xiamen Changrong Investment Management investment in Series B - Anji Pharmaceuticals
Kaitai Capital
Kaitai Capital investment in Venture Round - Anji Pharmaceuticals
Viva BioInnovator
Viva BioInnovator investment in Venture Round - Anji Pharmaceuticals
Viva Ventures Biotech Fund
Viva Ventures Biotech Fund investment in Series A - Anji Pharmaceuticals
JMCR Partners
JMCR Partners investment in Series A - Anji Pharmaceuticals
Viva Ventures Biotech Fund
Viva Ventures Biotech Fund investment in Series A - Anji Pharmaceuticals
JMCR Partners
JMCR Partners investment in Series A - Anji Pharmaceuticals
Viva Ventures Biotech Fund
Viva Ventures Biotech Fund investment in Seed Round - Anji Pharmaceuticals
JMCR Partners
JMCR Partners investment in Seed Round - Anji Pharmaceuticals
Official Site Inspections
http://www.anjipharma.com Semrush global rank: 9.03 M Semrush visits lastest month: 445
- Host name: 104.21.48.1
- IP address: 104.21.48.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Anji Pharmaceuticals"
Anji Pharmaceuticals - Crunchbase Company Profile & Funding
Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our strategy and execution.See details»
Anji Pharma: Contact Details and Business Profile
Anjipharma.com; truelinetx.com; 2 937265XXXX; 989430XXXX; View Similar People. Related Companies Factor Bioscience Inc. 10 $7m Amylyx Pharmaceuticals. 395 $4m Boston …See details»
Anji Pharma - LinkedIn
Anji Pharma is a global pharmaceutical company focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our ...See details»
Anji Pharma - Company Profile & Staff Directory | ContactOut
Anji Pharma is a global pharmaceutical company focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our …See details»
Anji Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.anjipharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The …See details»
Anji Pharma Company Profile 2024: Valuation, Funding ... - PitchBook
Anji Pharma General Information Description. Producer of metabolic drugs intended to provide medical cure treatment for chronic diseases. The company's drugs help cure chronic diseases …See details»
Anji Pharma and Population Health Partners Enter into Strategic ...
Oct 19, 2022 For more info, visit www.anjipharma.com. About Population Health Partners, L.P. Population Health Partners, L.P. is a private equity firm committed to building great companies …See details»
Anji Pharmaceuticals - Viva BioInnovator
Www.anjipharma.com. location. China, Shanghai/USA, Massachusetts. modality. Small Molecule. Indications. Metabolic. Anji Pharma is a clinical-stage biotech company with operations in the …See details»
Anji Pharma Secures $70 Million to Deploy Dynamic Equity and …
Sep 28, 2021 For more info, visit www.anjipharma.com. For legal matters, Anji is advised by Foley Hoag LLP, a seasoned team deeply rooted in the Boston-area entrepreneurial ecosystem.See details»
Anji Pharma Launches Phase 3 Trial for ANJ900 to Treat Type 2 …
Jun 10, 2021 CAMBRIDGE, Mass. & SHANGHAI--(BUSINESS WIRE)--Anji Pharma (“Anji”) has initiated a pivotal trial of ANJ900 (delayed-release metformin) in patients with Type 2 diabetes …See details»
Anji Pharma Secures $70 Million to Deploy Dynamic Equity and …
Sep 28, 2021 CAMBRIDGE, Mass., & SHANGHAI--(BUSINESS WIRE)-- Anji Pharma (“Anji”), an emerging global medicines company, today announced the close of a $70 million Series B …See details»
Anji Pharma and Population Health Partners Enter into Strategic ...
For more info, visit www.anjipharma.com. About Population Health Partners, L.P. Population Health Partners, L.P. is a private equity firm committed to building great companies around …See details»
Anji Pharma Announces Formation of Clinical Advisory Board for …
Jun 2, 2022 Anji Pharma, an emerging global medicines company, today announced the formation of a clinical advisory board to support its lead program, ANJ900, a dSee details»
Anji Pharma nabs $70M for late-stage diabetes treatment, ex …
Sep 28, 2021 Anji Pharma wants to bring a Type 2 diabetes and chronic kidney disease treatment along with a constipation drug to market, and now the biotech has $70 million to …See details»
Anji Pharma Secures $70 Million to Deploy Dynamic Equity and …
Sep 28, 2021 CAMBRIDGE, Mass., & SHANGHAI– Anji Pharma (“Anji”), an emerging global medicines company, today announced the close of a $70 million Series B financing round to …See details»
Anji Pharma nabs $70M for late-stage diabetes treatment, ex …
Oct 5, 2021 Anji Pharma wants to bring a Type 2 diabetes and chronic kidney disease treatment along with a constipation drug to market, and now the biotech has $70 million to bankroll …See details»
Anji Pharma Provides Update on ANJ900 Pivotal Program
Jun 2, 2022 For more info, visit www.anjipharma.com, follow us on social media – Twitter: @AnjiPharmaUS, LinkedIn: @Anji Pharma, and subscribe to our YouTube channel. ContactsSee details»
Anji Pharma Closes $70 Million Series B - citybiz
Sep 28, 2021 CAMBRIDGE, Mass., & SHANGHAI–(BUSINESS WIRE)–Anji Pharma, an emerging global medicines company, today announced the close of a $70 million Series B …See details»
Anji Pharma Fully Enrolls Cohort at Leading Beijing Hospital to …
Nov 30, 2021 “The full enrollment of the Beijing study is an important milestone for our DREAM-T2D program and our multi-national clinical operations organization,” noted Greg Dombal, …See details»
Anji Pharma Launches Phase 3 Trial for ANJ900
Anji’s clinical pipeline is led by delayed-release metformin (ANJ900 – Ph3) for effective glucose management in patients with type 2 diabetes and advanced chronic kidney disease, followed …See details»